Skip to main content

Advertisement

Log in

Extracranial metastatic patterns on occurrence of brain metastases

  • Clinical Study - Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Extracranial metastases and their frequency by sites have been described as prognostic factors for survival of patients with brain metastasis. However, these factors must be identified and described in more detail for a large series of patients. Using routine data from the largest German health insurance fund, 5,074 patients with brain metastasis who were diagnosed and treated in 2008 were analyzed to identify the frequency and distribution of extracranial metastatic sites concurrent with brain metastasis in relation to age, gender, and tumor type. Brain metastases were observed in males more frequently than in females (56.4 and 43.6% respectively P < 0.001), and were most often from lung (51.2%), breast (12.3%), and unknown (7.5%) primaries. Extracranial metastatic sites were observed in 58.8% of patients; the number of sites was from 1 to 7, with a mean of 1.11. For the 16 most common primary sites the range was from 0.13 to 1.91 . In 11 of these 16 sites, lungs were the most common concurrent metastatic site. Lung cancer, breast cancer, non-Hodgkin’s lymphoma, and testicular cancer most commonly metastasized to bone, and bladder cancer to kidneys. Different primary tumors have different frequencies and patterns of extracranial metastatic sites concurrently with brain metastasis. The lung is the most common metastatic site of most primary tumors, bone for a few tumors, and kidneys for bladder cancer. For the unknown primary tumor type, screening for these most common metastatic sites must be intensified, in particular when molecular assessment is not available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Morris SL, Low SH, A’Hern RP, Eisen TG, Gore ME, Nutting CM, Harrington KJ (2004) A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 91:829–833

    PubMed  CAS  Google Scholar 

  2. Delattre JY, Krol G, Thaler HT, Posner JB (1988) Distribution of brain metastases. Arch Neurol 45:741–744

    PubMed  CAS  Google Scholar 

  3. Aronson SM, Garcia JH, Aronson BE (1964) Metastatic neoplasms of the brain: their frequency in relation to age. Cancer 17:558–563

    Article  PubMed  CAS  Google Scholar 

  4. Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226

    PubMed  CAS  Google Scholar 

  5. Johnson JD, Young B (1996) Demographics of brain metastasis. Neurosurg Clin N Am 7:337–344

    PubMed  CAS  Google Scholar 

  6. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK (1978) Malignant melanoma and central nervous system metastases: Incidence, diagnosis, treatment and survival. Cancer 42:660–668

    Article  PubMed  CAS  Google Scholar 

  7. Chason JL, Walker FB, Landers JW (1963) Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study. Cancer 16:781–787

    Article  PubMed  CAS  Google Scholar 

  8. O’Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O’Fallon JR (2003) A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 55:1169–1176

    Article  PubMed  Google Scholar 

  9. Ranasinghe MG, Sheehan JM (2007) Surgical management of brain metastases. Neurosurg Focus 22(3):E2

    Article  PubMed  Google Scholar 

  10. Jeremic B, Becker G, Plasswilm L, Bamberg M (2000) Activity of extra-cranial metastases as a prognostic factor influencing survival after radiosurgery of brain metastases. J Cancer Res Clin Oncol 126:475–480

    Article  PubMed  CAS  Google Scholar 

  11. Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD (2005) Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:2784–2791

    Article  PubMed  Google Scholar 

  12. Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE (2007) Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 109:2515–2521

    Article  PubMed  Google Scholar 

  13. Itoh Y, Fuwa N, Morita K (2003) Radiation therapy for metastatic brain tumors from lung cancer—a review to devise individualized treatment plans. Nagoya J Med Sci 66:119–128

    PubMed  Google Scholar 

  14. Arteaga CLA, Hanauske AR, Clark GM, Osborne CK, Hazarika I, Pardue RL, Tio F, Hoff DDV (1988) Immunoreactive transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis. Cancer Res 48:5023–5028

    PubMed  CAS  Google Scholar 

  15. Cho KS, Choi YD, Kim SJ et al (2008) A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma. Yonsei Med J 49:451–458

    Article  PubMed  Google Scholar 

  16. Paralkar VR, Li T, Langer CJ (2008) Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a fox chase cancer center retrospective. Clin Lung Cancer 9:116–121

    Article  PubMed  Google Scholar 

  17. Pilgrim HI (1969) The kinetics of the organ-specific metastasis of a transplantable reticuloendothelial tumor. Cancer Res 29:1200–1205

    PubMed  CAS  Google Scholar 

  18. Guy DS, Samuel WF (2008) Metastatic patterns of cancers. Arch Pathol Lab Med 132:931–939

    Google Scholar 

  19. Isaiah JF (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458

    Article  Google Scholar 

  20. Bartelt S, Lutterbach J (2003) Brain metastases in patients with cancer of unknown primary. J Neurooncol 64:249–253

    Article  PubMed  Google Scholar 

  21. Khansur T, Routh A, Hickman B (1997) Brain metastases from unknown primary site. J Miss State Med Assoc 38:238–242

    PubMed  CAS  Google Scholar 

  22. Salvati M, Cervoni L, Raco A (1995) Single brain metastases from unknown primary malignancies in CT-era. J Neurooncol 23:75–80

    Article  PubMed  CAS  Google Scholar 

  23. AOK (2010) http://www.aok-business.de/wir-ueber-uns/wir-ueber-uns.php?id=0&gt=aok07&si=AOK71256224008463556. Accessed 1 Dec 2010

  24. WHO (2001) International classification of diseases for oncology, (ICD-O-3), 3rd edn. World Health Organization, Geneva

  25. DIMDI (2007) Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme 10. Revision version 2007. German modification. Vierstellige ausführliche Systematik. http://www.dimdi.de/static/de/klassi/diagnosen/icd10/. Accessed 1 December 2010

  26. Robert Koch Institute (ed) and Association of Population-based Cancer Registries in Germany (ed) (2008) Cancer in Germany 2003–2004. Incidence and trends, 6th edn. Berlin

  27. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 295:2483–2491

    Article  PubMed  CAS  Google Scholar 

  28. Berge T, Toremalm NG (1975) Bronchial cancer-a clinical and pathological study. I. Histopathology and metastases. Scand J Respir Dis 56:109–119

    PubMed  CAS  Google Scholar 

  29. Santarelli JG, Sarkissian V, Hou LC, Veeravagu A, Tse V (2007) Molecular events of brain metastasis. Neurosurg Focus 22(3):E1

    Article  PubMed  Google Scholar 

  30. Wronski M, Arbit E (1999) Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 85:1677–1685

    Article  PubMed  CAS  Google Scholar 

  31. Engenhart R, Kimmig BN, Höver KH, Wowra B, Romahn J, Lorenz WJ, van Kaick G, Wannenmacher M (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361

    Article  PubMed  CAS  Google Scholar 

  32. Joseph J, Adler JR, Cox RS, Hancock SL (1996) Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14:1085–1092

    PubMed  CAS  Google Scholar 

  33. Breneman JC, Warnick RE, Albright RE Jr, Kukiatinant N, Shaw J, Armin D, Tew J Jr (1997) Stereotactic radiosurgery for the treatment of brain metastases: results of a single institution series. Cancer 79:551–557

    Article  PubMed  CAS  Google Scholar 

  34. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD (1998) Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581–589

    Article  PubMed  CAS  Google Scholar 

  35. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106:1624–1633

    Article  PubMed  Google Scholar 

  36. Kebudi R, Ayan I, Görgün O, Ağaoğlu FY, Vural S, Darendeliler E (2005) Brain metastasis in pediatric extra-cranial solid tumors: survey and literature review. J Neurooncol 71:43–48

    Article  PubMed  Google Scholar 

  37. Aylin P, Bottle A, Majeed A (2007) Use of administrative data or clinical databases as predictors of risk of death in hospital: comparison of models. BMJ 334:1044–1047

    Article  PubMed  Google Scholar 

  38. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH (2004) Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 148:99–104

    Article  PubMed  Google Scholar 

  39. Luthi JC, Troillet N, Eisenring MC, Sax H, Burnand B, Quan H, Ghali W (2007) Administrative data outperformed single-day chart review for comorbidity measure. Int J Qual Health Care 19:225–231

    Article  PubMed  Google Scholar 

  40. Quan H, Parsons GA, Ghali WA (2002) Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40:675–685

    Article  PubMed  Google Scholar 

  41. McKee M, Britton A, Black N, McPherson K, Sanderson C, Bain C (1999) Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ (Clinical Research ed) 319:312–315

    CAS  Google Scholar 

  42. Eichler AF, Lamont EB (2009) Utility of administrative claims data for the study of brain metastases: a validation study. J Neurooncol 95:427–431

    Article  PubMed  Google Scholar 

  43. Busse R, Schreyögg J, Smith PC (2006) Hospital case payment systems in Europe. Health Care Manag Sci 9(3):211–213

    Article  PubMed  Google Scholar 

  44. Thieme M (2008) Krankenkassen mit ungebrochener Prüfungslust. KU Gesundheitsmanagement 78:48–52

    Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the scholarship provided by the Ministry of Education and Training of Vietnam (MOET) and the German Academic Exchange Service (DAAD); WIdO of Germany for kindly providing the dataset; and our colleagues in MiG-TU Berlin for help with data collection.

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Duong Anh Vuong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vuong, D.A., Rades, D., Vo, S.Q. et al. Extracranial metastatic patterns on occurrence of brain metastases. J Neurooncol 105, 83–90 (2011). https://doi.org/10.1007/s11060-011-0563-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0563-z

Keywords

Navigation